187 related articles for article (PubMed ID: 31721138)
1. Prenatal Exposure to Macrolides and Risk of Congenital Malformations: A Meta-Analysis.
Mallah N; Tohidinik HR; Etminan M; Figueiras A; Takkouche B
Drug Saf; 2020 Mar; 43(3):211-221. PubMed ID: 31721138
[TBL] [Abstract][Full Text] [Related]
2. Pregnancy outcome after gestational exposure to the new macrolides: a prospective multi-center observational study.
Bar-Oz B; Diav-Citrin O; Shechtman S; Tellem R; Arnon J; Francetic I; Berkovitch M; Ornoy A
Eur J Obstet Gynecol Reprod Biol; 2008 Nov; 141(1):31-4. PubMed ID: 18760873
[TBL] [Abstract][Full Text] [Related]
3. Fetal safety of macrolides.
Bahat Dinur A; Koren G; Matok I; Wiznitzer A; Uziel E; Gorodischer R; Levy A
Antimicrob Agents Chemother; 2013 Jul; 57(7):3307-11. PubMed ID: 23650169
[TBL] [Abstract][Full Text] [Related]
4. Associations between macrolide antibiotics prescribing during pregnancy and adverse child outcomes in the UK: population based cohort study.
Fan H; Gilbert R; O'Callaghan F; Li L
BMJ; 2020 Feb; 368():m331. PubMed ID: 32075790
[TBL] [Abstract][Full Text] [Related]
5. Use of macrolides during pregnancy and the risk of birth defects: a population-based study.
Bérard A; Sheehy O; Zhao JP; Nordeng H
Pharmacoepidemiol Drug Saf; 2015 Dec; 24(12):1241-8. PubMed ID: 26513406
[TBL] [Abstract][Full Text] [Related]
6. The outcomes of pregnancy in women exposed to the new macrolides in the first trimester: a prospective, multicentre, observational study.
Bar-Oz B; Weber-Schoendorfer C; Berlin M; Clementi M; Di Gianantonio E; de Vries L; De Santis M; Merlob P; Stahl B; Eleftheriou G; Maňáková E; Hubičková-Heringová L; Youngster I; Berkovitch M
Drug Saf; 2012 Jul; 35(7):589-98. PubMed ID: 22702640
[TBL] [Abstract][Full Text] [Related]
7. Associations between use of macrolide antibiotics during pregnancy and adverse child outcomes: A systematic review and meta-analysis.
Fan H; Li L; Wijlaars L; Gilbert RE
PLoS One; 2019; 14(2):e0212212. PubMed ID: 30779772
[TBL] [Abstract][Full Text] [Related]
8. Safety of macrolides during pregnancy.
Lin KJ; Mitchell AA; Yau WP; Louik C; Hernández-Díaz S
Am J Obstet Gynecol; 2013 Mar; 208(3):221.e1-8. PubMed ID: 23254249
[TBL] [Abstract][Full Text] [Related]
9. Macrolide and lincosamide antibiotic exposure in the first trimester of pregnancy and risk of congenital anomaly: A European case-control study.
Leke AZ; Dolk H; Loane M; Casson K; Nelen V; Barišić I; Garne E; Rissman A; O'Mahony M; Neville AJ; Pierini A; Bergman JEH; Klungsøyr K; Materna-Kiryluk A; Bielenska AL; Carbonell CC; Addor MC; Tucker D
Reprod Toxicol; 2021 Mar; 100():101-108. PubMed ID: 33454317
[TBL] [Abstract][Full Text] [Related]
10. Pregnancy outcomes following maternal macrolide use: A systematic review and meta-analysis.
Keskin-Arslan E; Erol H; Uysal N; Karadas B; Temiz T; Kaplan YC
Reprod Toxicol; 2023 Jan; 115():124-146. PubMed ID: 36549458
[TBL] [Abstract][Full Text] [Related]
11. Use of antibiotics during pregnancy and the risk of major congenital malformations: a population based cohort study.
Muanda FT; Sheehy O; Bérard A
Br J Clin Pharmacol; 2017 Nov; 83(11):2557-2571. PubMed ID: 28722171
[TBL] [Abstract][Full Text] [Related]
12. Use of macrolides in mother and child and risk of infantile hypertrophic pyloric stenosis: nationwide cohort study.
Lund M; Pasternak B; Davidsen RB; Feenstra B; Krogh C; Diaz LJ; Wohlfahrt J; Melbye M
BMJ; 2014 Mar; 348():g1908. PubMed ID: 24618148
[TBL] [Abstract][Full Text] [Related]
13. Prophylactic antibiotics for inhibiting preterm labour with intact membranes.
Flenady V; Hawley G; Stock OM; Kenyon S; Badawi N
Cochrane Database Syst Rev; 2013 Dec; (12):CD000246. PubMed ID: 24307518
[TBL] [Abstract][Full Text] [Related]
14. Association between antibiotic prescribing in pregnancy and cerebral palsy or epilepsy in children born at term: a cohort study using the health improvement network.
Meeraus WH; Petersen I; Gilbert R
PLoS One; 2015; 10(3):e0122034. PubMed ID: 25807115
[TBL] [Abstract][Full Text] [Related]
15. Benzodiazepine Use During Pregnancy Alone or in Combination With an Antidepressant and Congenital Malformations: Systematic Review and Meta-Analysis.
Grigoriadis S; Graves L; Peer M; Mamisashvili L; Dennis CL; Vigod SN; Steiner M; Brown C; Cheung A; Dawson H; Rector N; Guenette M; Richter M
J Clin Psychiatry; 2019 Jul; 80(4):. PubMed ID: 31294935
[TBL] [Abstract][Full Text] [Related]
16. The effect of second-trimester antibiotic therapy on the rate of preterm birth.
Morency AM; Bujold E
J Obstet Gynaecol Can; 2007 Jan; 29(1):35-44. PubMed ID: 17346476
[TBL] [Abstract][Full Text] [Related]
17. The association of prenatal and postnatal macrolide exposure with subsequent development of infantile hypertrophic pyloric stenosis: a systematic review and meta-analysis.
Almaramhy HH; Al-Zalabani AH
Ital J Pediatr; 2019 Feb; 45(1):20. PubMed ID: 30717812
[TBL] [Abstract][Full Text] [Related]
18. Use of antibiotics during pregnancy and risk of spontaneous abortion.
Muanda FT; Sheehy O; Bérard A
CMAJ; 2017 May; 189(17):E625-E633. PubMed ID: 28461374
[TBL] [Abstract][Full Text] [Related]
19. The safety of macrolides during lactation.
Goldstein LH; Berlin M; Tsur L; Bortnik O; Binyamini L; Berkovitch M
Breastfeed Med; 2009 Dec; 4(4):197-200. PubMed ID: 19366316
[TBL] [Abstract][Full Text] [Related]
20. [Restrict the use of macrolides in pregnant women: The advantages and disadvantages of research with data from health care databases].
Stricker BH
Ned Tijdschr Geneeskd; 2021 Jul; 165():. PubMed ID: 34346594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
